Chapter 37: Coronary Artery Disease and Acute Coronary Syndrome Flashcards

1
Q

What increases C-reactive protein (CRP) levels?

A

systemic inflammation or coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

High ____________ and ____________ levels may contribute to atherosclerosis

A

homocysteine, lipoprotein(a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathogenesis of atherosclerosis includes which four stages

A

chronic endothelial injury, fatty streak, fibrous plaque, complicated lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lipid-filled smooth muscle cells; lipids accumulate and migrate into smooth muscle cells

A

fatty streak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

collagen covers fatty streak, vessel lumen is narrowed, blood flow is reduced, fissures can develop

A

fibrous plaque

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

plaque rupture, thrombus formation, further narrowing or total occlusion of vessel

A

complicated lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

alternative arterial anastomoses or connections within the coronary circulation

A

collateral circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

nonmodifiable risk factors for coronary artery disease

A

age, gender, ethnicity, family history, genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

modifiable risk factors for coronary artery disease

A

high serum lipids, high blood pressure, tobacco use, physical inactivity, obesity, diabetes, metabolic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Men or women are more likely to die after their first MI

A

women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

four major modifiable risk factors for coronary artery disease

A

elevated serum lipids, hypertension, tobacco use, physical inactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

types of substance use most likely to contribute to coronary artery disease

A

cocaine, methamphetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

normal total cholesterol levels

A

<200 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

normal HDL levels

A

males: >45 mg/dL
females: >55 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

normal LDL levels

A

<130 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

normal triglyceride levels

A

males: 40-160 mg/dL
females 35-135 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

statin therapy is recommended for these four patients

A
  1. Patients with known CVD
  2. LDL cholesterol >190 mg/dL
  3. Age 40-75 with diabetes and LDL 70-189 mg/dL
  4. Age 40-75 with LDL 70-189 mg/dL and 10-year risk for CVD at least 7.5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

side effects of statins

A

rash, GI problems, increased liver enzymes, myopathy, rhabdomyolysis* (tea-colored urine, muscle pain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

side effects of niacin

A

flushing, pruritis, GI problems, orthostatic hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

gemfibrozil

A

fibric acid derivative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

fenofibrate

A

fibric acid derivative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

lipid-lowering drug class that interferes with GI and absorption of many different drugs (take _______ before eating or taking other drugs)

A

bile sequestrants, 2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

drug that further reduces LDL when used with a statin

A

ezetimibe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

drug used with high-risk hyperlipidemia to decrease cholesterol and associated 10-year risk

A

ezetimibe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
give this drug ___________ prior to reduce flushing associated with niacin
NSAID, 30 minutes
26
this lipid-lowering drug class increases hyperglycemia and interacts with metformin and antihyperglycemics
fibric acid derivatives
27
drugs in this class have "chole" or "cole" in drug name
bile acid sequestrants
28
angina that occurs intermittently over a long period of time with a similar pattern
chronic stable angina
29
angina that involves chest pain that is new in onset that occurs at rest or with increasing frequency and duration
unstable angina
30
variant and rare form of angina that occurs at rest and not with increased physical demand
Prinzmetal's angina
31
factors contributing to Prinzmetal's angina
substance use (alcohol, cocaine), caffeine use, medications that cause vasoconstriction, cold weather exposure
32
angina in which chest pain is related to myocardial ischemia from atherosclerosis or spasm of small distal branch vessels in coronary circulation
microvascular angina
33
acute care for angina (7 steps)
1. position upright (Fowler's), apply oxygen 2. assess vital signs, heart/breath sounds 3. continuous ECG; 12-lead ECG 4. pain relief (nitroglycerin, IV opioid if needed) 5. cardiac biomarkers 6. chest X-ray 7. support, reduce anxiety
34
gold standard cardiac biomarker
troponin
35
purpose of chest X-ray in patient with angina
see if heart is enlarged
36
give this drug for headache caused by nitroglycerin
acetaminophen
37
drugs that dilate peripheral and coronary arteries and collateral vessels
short-acting nitrates
38
when does SL NTG relieve angina
5 minutes after administration
39
how long does SL NTG last
30-40 minutes
40
how often can a dose of SL NTG be repeated
3 doses every 5 minutes
41
side effects of SL NTG
headache, dizziness, flushing, orthostatic hypotension
42
store NTG tablets away from _______ and _______
light, heat
43
NTG tablets should be replaced every ________ after the bottle is opened
6 months
44
prophylactic use of NTG
take tablet/spray 5-10 minutes before activity known to cause angina
45
drug class used for LV dysfunction, elevated BP, or MI
beta blockers
46
drug class in which drugs end in "lol"
beta blockers
47
drug class that causes vasodilation and decreases contractility
calcium channel blockers (CCBs)
48
drug class in which many of its drugs end in "dipine"
calcium channel blockers
49
diltiazem
calcium channel blocker
50
verapamil
calcium channel blocker
51
last-chance drug for control of chronic stable angina
ranolazine
52
three drug classes used to treat chronic stable angina
beta blockers, calcium channel blockers, sodium current inhibitor
53
diagnostic studies for chronic stable angina (7)
1. 12-lead ECG 2. Lab studies: cardiac biomarkers, lipid profile, CRP 3. chest x-ray 4. echocardiogram 5. exercise stress test 6. electron beam computed tomography 7. coronary computed tomography angiography
54
gold standard test for patients with increasing angina symptoms that can identify and localize CAD
cardiac catheterization
55
cardiac catheterization and PCI preprocedure nursing management (5)
1. allergies (contrast dye) 2. baseline assessment: vital signs, pulse ox, heart/breath sounds, neurovascular 3. baseline laboratory studies 4. administer ordered drugs 5. patient education for preprocedure and postprocedure care
56
cardiac catheterization and PCI postprocedure nursing management
1. compare assessments to preprocedure 2. assess catheter insertion site for hematoma, bleeding, bruit every 15 minutes for first hour, then agency policy 3. ECG for dysrhythmia; chest pain or other pain 4. IV infusion of antianginals 5. monitor for complications 6. educate: discharge care and drugs; signs and symptoms to report to HCP
57
three drugs used during PCI
unfractionated heparin or low-molecular weight heparin direct thrombin inhibitor glycoprotein IIb/IIIa inhibitor
58
drugs used after PCI
dual antiplatelet therapy (DAPT): aspirin and ticagrelor or clopidogrel
59
coronary artery bypass graft (CABG) surgery recommended in these four situations
1. medical treatment failed 2. disease involves left main coronary artery or three vessels 3. PCI cannot be done 4. failed PCI or chest pain continues
60
coronary artery bypass graft (CABG) is an option in those who have any of these three conditions
diabetes, left ventricular dysfunction (LVD), chronic kidney disease (CKD)
61
two treatment options for STEMI
cardiac catheterization (if available at hospital): 90 minutes door to balloon if cardiac catheterization not available, start thrombolytic therapy
62
treatment for NSTEMI
cardiac catheterization within 12-72 hours
63
chest pain from ischemia is prolonged and not immediately reversible
acute coronary syndrome (ACS)
64
acute coronary syndrome (ACS) occurs on a spectrum from _____________ to ______________
non-ST elevation ACS (UA and NSTEMI) STEMI
65
diagnostic studies for acute coronary syndrome (ACS)
12-lead ECG, serum cardiac biomarkers
66
serum cardiac biomarkers for ACS
proteins released after MI cardiac-specific troponin T (cTNT) cardiac-specific troponin I (cTNI)
67
serum cardiac biomarkers are _________ for UA and ___________ for NSTEMI
negative, positive
68
________________ are better indicators of MI than _________ or ____________ (serum cardiac biomarkers)
cardiac-specific troponins, CK-MB, myoglobin
69
partial occlusion of coronary artery indicates _____ or ______
UA, NSTEMI
70
total occlusion of coronary artery indicates ________
STEMI
71
first treatment with confirmed STEMI
emergent PCI
72
two types of stents that may be used in emergent PCI
bare-metal stent (BMS), drug-eluting stent (DES)
73
with emergent PCI, patients with severe LV dysfunction may require ____________ and/or __________
VAD therapy, inotropes
74
five advantages of PCI (vs. CABG)
1. faster reperfusion to limit infarction size 2. performed with IV sedation and local anesthesia 3. ambulatory shortly after procedure 4. shorter length of stay 5. faster return to work
75
complications of PCI (6)
1. dissection or rupture of coronary artery 2. abrupt artery closure 3. acute stent thrombosis 4. failure to cross blockage with balloon or stent 5. extended infarction 6. in-stent restenosis
76
acute care for ACS after admitted to ICU/telemetry unit
1. monitor VS and pulse oximetry 2. continuous ECG 3. serial 12-lead ECGs 4. serial cardiac biomarkers 5. bed rest/limit activity
77
how long should an ACS patient be on bed rest and limit activity for when admitted to ICU/telemetry unit
12-24 hours (then increase gradually)